Submitted by: Submitted by marketresearchri
Views: 10
Words: 1152
Pages: 5
Category: Science and Technology
Date Submitted: 10/19/2016 12:48 AM
Oxysterols Receptor LXR-Beta Market Share, Size, Treatment,
Symptoms, Pipeline Review, H1 2016
Summary
Global Markets Direct's, 'Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear
Receptor Subfamily 1 Group H Member 2 or NR1H2 or LXRB) - Pipeline Review, H1 2016', provides in depth
analysis on Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor
Subfamily 1 Group H Member 2 or NR1H2 or LXRB) targeted pipeline therapeutics.
The report provides comprehensive information on the Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or
Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or NR1H2 or LXRB), targeted
therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases. Additionally, the
report provides an overview of key players involved in Oxysterols Receptor LXR-Beta (Liver X Receptor Beta or
Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or NR1H2 or LXRB) targeted
therapeutics development and features dormant and discontinued projects.
Browse Ongoing Reports @ http://www.radiantinsights.com/research/oxysterols-receptor-lxr-beta
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and
nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third party sources.
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to...